204 related articles for article (PubMed ID: 27877049)
1. A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus.
Derosa G; Maffioli P
Vasc Health Risk Manag; 2016; 12():415-419. PubMed ID: 27877049
[TBL] [Abstract][Full Text] [Related]
2. Retinol-binding protein-4 is associated with endothelial dysfunction in adults with newly diagnosed type 2 diabetes mellitus.
Park SE; Kim DH; Lee JH; Park JS; Kang ES; Ahn CW; Lee HC; Cha BS
Atherosclerosis; 2009 May; 204(1):23-5. PubMed ID: 18838136
[No Abstract] [Full Text] [Related]
3. Increased plasma advanced oxidation protein products is an early marker of endothelial dysfunction in type 2 diabetes patients without albuminuria 2.
Liang M; Wang J; Xie C; Yang Y; Tian JW; Xue YM; Hou FF
J Diabetes; 2014 Sep; 6(5):417-26. PubMed ID: 24506465
[TBL] [Abstract][Full Text] [Related]
4. Markers of endothelial dysfunction and low-grade inflammation are associated in the offspring of type 2 diabetic subjects.
Ruotsalainen E; Vauhkonen I; Salmenniemi U; Pihlajamäki J; Punnonen K; Kainulainen S; Jalkanen S; Salmi M; Laakso M
Atherosclerosis; 2008 Mar; 197(1):271-7. PubMed ID: 17560580
[TBL] [Abstract][Full Text] [Related]
5. Effects of percutaneous lower-extremity arterial interventions on endothelial function and inflammation response in patients with both type 2 diabetes and lower-extremity peripheral arterial disease.
Du Y; Wang F; Qi H; Ding H; Hou L; Gao Q; Tan M; Liu Y; Xing N; Sun J
Int J Clin Exp Pathol; 2015; 8(7):8115-21. PubMed ID: 26339379
[TBL] [Abstract][Full Text] [Related]
6. Non-transferrin-bound iron is associated with biomarkers of oxidative stress, inflammation and endothelial dysfunction in type 2 diabetes.
Aljwaid H; White DL; Collard KJ; Moody AJ; Pinkney JH
J Diabetes Complications; 2015; 29(7):943-9. PubMed ID: 26104728
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC Cohort.
Hunt KJ; Baker NL; Cleary PA; Klein R; Virella G; Lopes-Virella MF;
Diabetes Care; 2015 Jul; 38(7):1281-9. PubMed ID: 25852210
[TBL] [Abstract][Full Text] [Related]
8. Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetes.
Tremblay AJ; Lamarche B; Deacon CF; Weisnagel SJ; Couture P
Metabolism; 2014 Sep; 63(9):1141-8. PubMed ID: 25034387
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of vascular injury and endothelial dysfunction after recent glucose intolerance in pregnancy.
Bajaj HS; Ye C; Hanley AJ; Sermer M; Zinman B; Retnakaran R
Diab Vasc Dis Res; 2018 Sep; 15(5):449-457. PubMed ID: 29871496
[TBL] [Abstract][Full Text] [Related]
10. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.
Caballero AE; Arora S; Saouaf R; Lim SC; Smakowski P; Park JY; King GL; LoGerfo FW; Horton ES; Veves A
Diabetes; 1999 Sep; 48(9):1856-62. PubMed ID: 10480619
[TBL] [Abstract][Full Text] [Related]
11. Flow-Mediated Skin Fluorescence (FMSF) Technique for Studying Vascular Complications in Type 2 Diabetes.
Katarzynska J; Borkowska A; Los A; Marcinek A; Cypryk K; Gebicki J
J Diabetes Sci Technol; 2020 May; 14(3):693-694. PubMed ID: 31855069
[No Abstract] [Full Text] [Related]
12. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications.
Goldberg RB
J Clin Endocrinol Metab; 2009 Sep; 94(9):3171-82. PubMed ID: 19509100
[TBL] [Abstract][Full Text] [Related]
13. Role of MCP-1 in tumor necrosis factor-alpha-induced endothelial dysfunction in type 2 diabetic mice.
Yang J; Park Y; Zhang H; Gao X; Wilson E; Zimmer W; Abbott L; Zhang C
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1208-16. PubMed ID: 19666844
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross-sectional study.
Walther G; Obert P; Dutheil F; Chapier R; Lesourd B; Naughton G; Courteix D; Vinet A
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):1022-9. PubMed ID: 25657309
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation.
Devaraj S; Jialal I
Circulation; 2000 Jul; 102(2):191-6. PubMed ID: 10889130
[TBL] [Abstract][Full Text] [Related]
16. [Adhesion molecules in type 2 diabetes].
Sokup A
Przegl Lek; 2005; 62(4):234-7. PubMed ID: 16229242
[TBL] [Abstract][Full Text] [Related]
17. Associations between Adiponectin Gene Variability, Proinflammatory and Angiogenetic Markers: Implications for Microvascular Disease Development in Type 2 Diabetes Mellitus?
Kollia C; Antonopoulos AS; Siasos G; Konsola T; Oikonomou E; Gouliopoulos N; Tsigkou V; Papapanagiotou A; Kassi E; Tentolouris N; Katsiki N; Vavuranakis M; Papavassiliou AG; Tousoulis D
Curr Vasc Pharmacol; 2019; 17(2):204-208. PubMed ID: 29308741
[TBL] [Abstract][Full Text] [Related]
18. [Correlation analysis between biochemical and biophysical markers of endothelium damage in children with diabetes type 1].
Głowińska-Olszewska B; Urban M; Tołwińska J; Peczyńska J; Florys B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(4):221-7. PubMed ID: 16232360
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial evaluating the impact of targeted vitamin D supplementation on endothelial function in type 2 diabetes mellitus: The DIMENSION trial.
Dalan R; Liew H; Assam PN; Chan ES; Siddiqui FJ; Tan AW; Chew DE; Boehm BO; Leow MK
Diab Vasc Dis Res; 2016 May; 13(3):192-200. PubMed ID: 26818228
[TBL] [Abstract][Full Text] [Related]
20. Arterial stiffness, hypertension and diabetes mellitus.
Cockcroft JR; Webb DJ; Wilkinson IB
J Hum Hypertens; 2000 Jun; 14(6):377-80. PubMed ID: 10878698
[No Abstract] [Full Text] [Related]
[Next] [New Search]
